ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.45 CNY | -4.33% |
|
+4.18% | +18.95% |
| May. 02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
| Apr. 29 | Zhejiang Huahai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 10.1B 1.4B | Sales 2025 * | 11.41B 1.58B | Capitalization | 25.56B 3.54B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.12B 155M | Net income 2025 * | 1.42B 196M | EV / Sales 2024 * | 2.78 x |
| Net Debt 2024 * | 2.54B 351M | Net Debt 2025 * | 2.31B 320M | EV / Sales 2025 * | 2.44 x |
| P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
17.9
x | Employees | 8,221 |
| Yield 2024 * |
1.23% | Yield 2025 * |
1.66% | Free-Float | 56.08% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.33% | ||
| 1 week | +4.18% | ||
| Current month | +4.18% | ||
| 1 month | +23.50% | ||
| 3 months | +29.74% | ||
| 6 months | +10.23% | ||
| Current year | +18.95% |
1 week
16.71
18.36
1 month
14.3118.36
Current year
10.7118.36
1 year
10.7119.10
3 years
10.7127.46
5 years
10.7145.70
10 years
7.4345.70
| Managers | Title | Age | Since |
|---|---|---|---|
Mei Zhang
DFI | Director of Finance/CFO | 48 | 08-05-31 |
Bao Hua Chen
PSD | President | 62 | 07-03-31 |
Si Jia Guo
BRD | Director/Board Member | 61 | 17-04-20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bao Hua Chen
PSD | President | 62 | 07-03-31 |
Yong Hua Zhu
BRD | Director/Board Member | 59 | - |
Jin Guo Xin
BRD | Director/Board Member | 62 | 19-05-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.57% | 0 M€ | -12.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 17.45 | -4.33% | 28,627,150 |
| 24-05-09 | 18.24 | +3.58% | 23,882,880 |
| 24-05-08 | 17.61 | -1.01% | 15,993,850 |
| 24-05-07 | 17.79 | +1.83% | 21,318,220 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotes
ZHEJIANGHUAHAIPHARMACEUTICALCO., LTD is a China-based company, principally engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs), intermediates and preparations. The Company's main products are classified as -pril series, -sartan series and preparations, including irbesartan tablets, paroxetine hydrochloride tablets, risperidone tablets, fosinopril sodium tablets, as well as irbesartan and hydrochlorothinzide tablets, among others. The Company also provides related technical support services. The Company distributes its products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
17.45
CNY
Average target price
18.17
CNY
Spread / Average Target
+4.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +18.95% | 3.54B | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- 600521 Stock
